… for treatment of lepromatous leprosy. Antimicrob Agents Chemother. 1994;38:662-7. …
clofazimine for treatment of lepromatous leprosy. Antimicrob Agents Chemother. 1994;38:662-7. …

… to leprosy in general and to multidrug therapy in particular. However, most African … with
leprosy cases adopted the new therapy after elaborate pilot multidrug therapy projects …

… the treatment. We report here the efficacy and the safety ot‘ our daily multidrug regimens …
The BT patient had LRR 10 days after cessation of treatment; the lepromatous patients‘ LRR …

… dapsone before MDT and which required treatment with prednisolone were included. Until
… % of 266 borderline lepromatous (BL) patients and in 19.2% of 109 lepromatous leprosy (LL) …

… the drugs used in multidrug treatment of leprosy]. Hansen Int, 1995; 20: 5–8. Lechat M. …
Multidrug therapy against leprosy. Development and implementation over the past 25 years. …

… treatment of leprosy. Until today, dapsone has been an integral component of any multidrug
therapy… In this context, patients with lepromatous leprosy are considered to be most …

… A daily dosage of 500 mg to a lepromatous leprosy patient kills 99% of lepra bacilli in 28
days and 99.9% by 56 days.^3'^^ Studies conducted on mouse foot-pad have confirmed the …

SciELO - Brasil - Identification of clinical, epidemiological and laboratory risk factors for leprosy
reactions during and after multidrug therapy Identification of clinical, epidemiological and …

… Multidrug therapy (MDT) is used for the treatment of leprosy patients. Major drugs of
choice are rifampicin, clofazimine and dapsone. Citation1 According to the World Health …

… A second study conducted in Brazil with a similar study design in patients with borderline
lepromatous and lepromatous leprosy demonstrated a similar fall in BI and similar clinical and …